V029-5610 Screening compound: 4-[2-({[5-(METHOXYMETHYL)-4-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}METHYL)BENZOYL]MORPHOLINE

V029-5610 Screening compound: 4-[2-({[5-(METHOXYMETHYL)-4-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}METHYL)BENZOYL]MORPHOLINE
V029-5610 Screening compound: 4-[2-({[5-(METHOXYMETHYL)-4-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}METHYL)BENZOYL]MORPHOLINE alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-5610
4-[2-({[5-(METHOXYMETHYL)-4-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}METHYL)BENZOYL]MORPHOLINE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-5610

Molecular Formula

C23H26N4O4S (C23 H26 N4 O4 S)

Compound Name

4-[2-({[5-(METHOXYMETHYL)-4-(4-METHOXYPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}METHYL)BENZOYL]MORPHOLINE

IUPAC name

4-[2-({[5-(methoxymethyl)-4-(4-methoxyphenyl)-4H-124-triazol-3-yl]sulfanyl}methyl)benzoyl]morpholine

SMILES

COCc(n1-c(cc2)ccc2OC)nnc1SCc(cccc1)c1C(N1CCOCC1)=O

InChI

InChI=1S/C23H26N4O4S/c1-29-15-21-24-25-23(27(21)18-7-9-19(30-2)10-8-18)32-16-17-5-3-4-6-20(17)22(28)26-11-13-31-14-12-26/h3-10H,11-16H2,1-2H3

InChI Key

FYOMXHZIMUPFPJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27633245

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

454.55

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.255

Distribution Coefficient, logD

2.255

Water Solubility, LogSw

-2.73

Polar Surface Area

66.485

Acid Dissociation Constant (pKa)

22.98

Base Dissociation Constant (pKb)

1.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

V029-5610 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V029-5610 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-5610?
Check Price and Availability of V029-5610, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-5610 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-5610
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-5610
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-5610 available by request